BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31399339)

  • 1. Healthcare resource utilization and costs before and after lacosamide initiation as adjunctive therapy among patients with epilepsy in the United States.
    Fishman J; Martin M; Labiner DM; Lew CR; Johnson BH
    Epilepsy Behav; 2019 Oct; 99():106331. PubMed ID: 31399339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and economic burden of breakthrough seizures.
    Divino V; Petrilla AA; Bollu V; Velez F; Ettinger A; Makin C
    Epilepsy Behav; 2015 Oct; 51():40-7. PubMed ID: 26255884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
    Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C
    Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The challenges of assessing effectiveness of lacosamide using electronic medical record databases.
    Kalilani L; Halpern R; Seare J; Dedeken P
    Epilepsy Behav; 2018 Aug; 85():195-199. PubMed ID: 30032807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiepileptic Drug Titration and Related Health Care Resource Use and Costs.
    Fishman J; Kalilani L; Song Y; Swallow E; Wild I
    J Manag Care Spec Pharm; 2018 Sep; 24(9):929-938. PubMed ID: 29486142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of hospitalization among patients with epilepsy using long versus short half-life adjunctive antiepileptic drugs.
    Cramer JA; Yan T; Tieu R; Knoth RL; Fincher C; Malhotra M; Choi J
    Epilepsy Behav; 2020 Jan; 102():106634. PubMed ID: 31783318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lacosamide as a first-line treatment option in focal epilepsy: a cost-utility analysis for the Greek healthcare system.
    Geitona M; Stamuli E; Giannakodimos S; Kimiskidis VK; Kountouris V; Charokopou M; Christou P
    J Med Econ; 2019 Apr; 22(4):359-364. PubMed ID: 30652931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013 - A ten-year overview.
    Willems LM; Richter S; Watermann N; Bauer S; Klein KM; Reese JP; Schöffski O; Hamer HM; Knake S; Rosenow F; Strzelczyk A
    Epilepsy Behav; 2018 Jun; 83():28-35. PubMed ID: 29649671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A long-term noninterventional safety study of adjunctive lacosamide therapy in patients with epilepsy and uncontrolled partial-onset seizures.
    Steinhoff BJ; Eckhardt K; Doty P; De Backer M; Brunnert M; Schulze-Bonhage A
    Epilepsy Behav; 2016 May; 58():35-43. PubMed ID: 27054272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lacosamide on background eeg activity in brain tumor-related epilepsy patients: A case series study.
    Maschio M; Zarabla A; Maialetti A; Sperati F; Dinapoli L; Dispenza S; Petreri G; Cantelmi T
    Brain Behav; 2018 Nov; 8(11):e01067. PubMed ID: 30334378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy upon 12-weeks after achievement of maximal dose and tolerability of lacosamide as an adjunctive therapy in epilepsy: Real world clinical experience.
    Chang RS; Lui HKK; Lui HTC; Leung CYW; Leung YHI; Wang YO
    J Neurol Sci; 2020 Feb; 409():116601. PubMed ID: 31801052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalization.
    Manjunath R; Paradis PE; Parisé H; Lafeuille MH; Bowers B; Duh MS; Lefebvre P; Faught E
    Neurology; 2012 Oct; 79(18):1908-16. PubMed ID: 23077014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Early Initiation of Eslicarbazepine Acetate on Economic Outcomes Among Patients with Focal Seizure: Results from Retrospective Database Analyses.
    Mehta D; Davis M; Epstein AJ; Wensel B; Grinnell T; Williams GR
    Neurol Ther; 2020 Dec; 9(2):585-598. PubMed ID: 32949379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lacosamide and concomitant use of antiepileptic and other medications in a US population - A retrospective cohort study.
    Kalilani L; Lu C; Pierre-Louis B; Gold M
    Epilepsy Behav; 2017 Jul; 72():51-57. PubMed ID: 28575767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
    Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
    Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world treatment patterns, healthcare resource utilisation and costs in patients with systemic lupus erythematosus treated with belimumab: a retrospective analysis of claims data in the USA.
    Bell CF; Priest J; Stott-Miller M; Kan H; Amelio J; Song X; Limone B; Noxon V; Costenbader KH
    Lupus Sci Med; 2020; 7(1):e000357. PubMed ID: 32341790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
    Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F
    Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany.
    Strzelczyk A; Haag A; Reese JP; Nickolay T; Oertel WH; Dodel R; Knake S; Rosenow F; Hamer HM
    Epilepsy Behav; 2013 Jun; 27(3):433-8. PubMed ID: 23591262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel action of lacosamide on GABA
    Ruffolo G; Di Bonaventura C; Cifelli P; Roseti C; Fattouch J; Morano A; Limatola C; Aronica E; Palma E; Giallonardo AT
    Neurobiol Dis; 2018 Jul; 115():59-68. PubMed ID: 29621596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.